Medical Journals

Annexin 1, Glucocorticoids, and the Neuroendocrine-immune Interface.

Authors:
  • Buckingham Julia C
  • John Christopher D
  • Solito Egle
  • Tierney Tanya
  • Flower Roderick J
  • Christian Helen
  • Morris John

From: Division of Neuroscience and Mental Health, Imperial College London, Hammersmith Campus, London W12 0NN, UK. j.buckingham@imperial.ac.uk

Annals of the New York Academy of Sciences

  • Publish Date: Nov 2006
  • ISSN: 0077-8923
  • Volume: 1088
  • Issue:
  • Pages: 396-409
  • Medium: Print
  • Language: English
  • Citation (JAMA): Buckingham Julia C, John Christopher D, Solito Egle, et al. Annexin 1, Glucocorticoids, and the Neuroendocrine-immune Interface.. Ann. N. Y. Acad. Sci. Nov 2006;1088:396-409

Abstract

Annexin 1 (ANXA1) was originally identified as a mediator of the anti-inflammatory actions of glucocorticoids (GCs) in the host defense system. Subsequent work confirmed and extended these findings and also showed that the protein fulfills a wider brief and serves as a signaling intermediate in a number of systems. ANXA1 thus contributes to the regulation of processes as diverse as cell migration, cell growth and differentiation, apoptosis, vesicle fusion, lipid metabolism, and cytokine expression. Here we consider the role of ANXA1 in the neuroendocrine system, particularly the hypothalamo-pituitary-adrenocortical (HPA) axis. Evidence is presented that ANXA1 plays a critical role in effecting the negative feedback effects of GCs on the release of corticotrophin (ACTH) and its hypothalamic-releasing hormones and that it is particularly pertinent to the early-onset actions of the steroids that are mediated via a nongenomic mechanism. The paracrine/juxtacrine mode of ANXA1 action is discussed in detail, with particular reference to the significance of the secondary processing of ANXA1, the processes that control the intracellular and transmembrane trafficking of the protein of the molecule and the mechanism of ANXA1 action on its target cells. In addition, the role of ANXA1 in the perinatal programming of the HPA axis is discussed.

Mesh Headings (Keywords): Animals, Annexin A1, Glucocorticoids, Humans, Neuroimmunomodulation, Neurosecretory Systems, Paracrine Communication, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 17192583


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.